Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.1%

- Check22 days agoChange DetectedAdded Revision: v3.4.3 to the record history and removed Revision: v3.4.2.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page history shows a new revision tag (v3.4.2) and the removal of a prior government funding status notice, which do not affect study data or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check58 days agoChange DetectedA new version entry (Revision: v3.4.1) was added to the record history, along with a site-wide notice about government funding and operating status; the previous version (v3.4.0) was removed from this history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check65 days agoChange DetectedUI changes include a glossary toggle and color-coding explanations for added (green) and deleted (red) items on the history page. The revision tag was updated to v3.4.0 and the No FEAR Act Data label was removed from the display.SummaryDifference1%

- Check79 days agoChange DetectedA new revision entry, Revision: v3.3.4, was added to the Study Record Versions list, and the previous Revision: v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.